Brown Advisory’s Array Biopharma Inc ARRY Stock Holding History

Brown Advisory’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,405,081	Closed	-$65.1M	–	1055
2019 Q2	$65.1M	Buy	1,405,081 +441,654	+46%	+$12.4M	0.19%	106
2019 Q1	$23.5M	Buy	963,427 +949,421	+6,779%	+$19.8M	0.07%	228
2018 Q4	$200K	Sell	14,006 -320	-2%	-$4.85K	﹤0.01%	1181
2018 Q3	$218K	Sell	14,326 -7,347	-34%	-$113K	﹤0.01%	1235
2018 Q2	$364K	Sell	21,673 -19	-0.1%	-$302	﹤0.01%	1050
2018 Q1	$354K	Buy	+21,692	New	+$347K	﹤0.01%	919
2016 Q3	–	Sell	-11,290	Closed	-$40K	–	1109
2016 Q2	$40K	Hold	11,290	–	–	﹤0.01%	1033
2016 Q1	$33K	Hold	11,290	–	–	﹤0.01%	985
2015 Q4	$48K	Sell	11,290 -550	-5%	-$2.51K	﹤0.01%	942
2015 Q3	$54K	Buy	+11,840	New	+$70.2K	﹤0.01%	922
2015 Q2	–	Sell	-11,840	Closed	-$88K	–	937
2015 Q1	$88K	Buy	+11,840	New	+$84.3K	﹤0.01%	914

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Brown Advisory's ARRY Position: Q3 2019 in Review

Brown Advisory sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 1,405,081 shares — an estimated $65.1M sold.

Brown Advisory first reported a position in ARRY in Q1 2015 and held it in 11 quarters. The position peaked at $65.1M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Brown Advisory reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Brown Advisory sold 1,405,081 Array Biopharma Inc shares in Q3 2019, an estimated $65.1M.
Brown Advisory first reported a position in Array Biopharma Inc in Q1 2015 and held it in 11 quarters.
Brown Advisory's Array Biopharma Inc position peaked at $65.1M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Brown Advisory's 13F filing for Q3 2019, filed 14 Nov 2019.